Articles On Volpara Health Technologies (ASX:VHT)

Title Source Codes Date
Closing Bell: Small caps dive, but Terragen jumps moon after testing proves its sci-fi cow feed really is an anti-methane fart machine

ASX posts 0.5% gain on Thursday Small caps retreat as commodities tread water US stocks futures pointing ~0.9% higher The resources heavy ASX Emerging Companies (XEC) index is down about 0.5% on Thursday, with both oil and the major commo...

Stockhead VHT 1 year ago
2 rapidly growing ASX shares that are on sale: experts

Some ASX shares are displaying rampant growth. Despite that, there are a number that have fallen heavily in recent times. While a lower share price doesn’t mean a business is necessarily better value, it does mean that the market capitalis...

Motley Fool VHT 1 year ago
Volpara Health Technologies (ASX:VHT) reshuffles leadership to reflect “pivotal” period

Volpara Health Technologies (VHT) makes changes to its leadership team to support its next phase of growth and innovation Dr Ralph Highnam will be transitioning to Chief Science and Innovation Officer after 13 years as Group CEO, and will...

themarketherald.com.au VHT 1 year ago
Volpara Health announces leadership and board changes

Volpara Health Technologies (ASX:VHT) has announced changes to its board and leadership team in a move it says is designed to support its next phase of growth.

BiotechDispatch VHT 1 year ago
2 great ASX shares to buy in April: experts

Experts have named some ASX shares as buys, and April 2022 could be the time to jump on these opportunities. When a business generates a lot of revenue growth, it could lead to elevated compound growth over time. Here are two ASX shares th...

Motley Fool VHT 1 year ago
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in ASX health stocks. Good news for coffee lovers, particularly those w...

Stockhead VHT 1 year ago
2 high-quality ASX shares I’d buy in April 2022

I think that in periods of uncertainty and volatility, high-quality ASX shares could be the way to go. Quality could mean different things to different people. It could mean great management. Quality could mean the resilience of earnings. I...

Rask Media VHT 2 years ago
Do ASX biotech shares offer ‘good buying’ after the sell-off? Experts weigh in

ASX biotech shares have, as a whole, had a remarkably poor run over the last 6 months. Here’s what we mean. Over the past 6 months, the All Ordinaries Index (ASX: XAO) is down 2.2%. Not what you’d like to see. But not close to gut wrenchin...

Motley Fool VHT 2 years ago
2 ASX tech shares I would love to buy

There are some outstanding ASX tech shares that I would like to buy for my portfolio. During these times of severe volatility, mostly declines, some excellent opportunities are opening up for investors. A business isn’t a buy just because i...

Rask Media VHT 2 years ago
ScoPo’s Powerplays: These ASX health stocks are under the radar as market wallows

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Through the destruction of war...

Stockhead VHT 2 years ago
2 ASX growth shares to buy this month: experts

The ASX share market continues to be volatile, which gives investors the opportunity to buy ASX growth shares at cheaper prices. Businesses that are still growing revenue whilst the share price falls could be an idea for investors to look...

Motley Fool VHT 2 years ago
Down 33% in 2022, is this ASX healthcare share a buy following the company’s latest trial result?

Shares in Volpara Health Technologies Ltd (ASX: VHT) finished trading on Thursday up 4.51% in the green at 70 cents. Investors appeared to be reacting positively to a company announcement from Volpara today. Even though the release wasn’t...

Motley Fool VHT 2 years ago
4 ASX healthcare shares at 52-week lows

Plenty of ASX healthcare shares fell to 52-week lows today. The industry has not been immune to the ASX share market selloff. There is ongoing volatility with investors keeping an on the Russian conflict with Ukraine, the sanctions and the...

Motley Fool VHT 2 years ago
Down over 30% in 2022: 2 compelling ASX tech shares

This year has already seen a lot of volatility on the ASX share market. Some ASX tech shares have fallen more than 30% since the start of 2022. Lower prices for businesses may not necessarily mean that they are better value. But, it could...

Motley Fool VHT 2 years ago
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks

In this week’s ScoPo’s Powerplays, healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, examines the turbulent start to 2022 for ASX health stocks and what could lie ahead as ge...

Stockhead VHT 2 years ago
What to do about this crazy ASX 200 share market?

The ASX 200 (ASX: XJO) share market has had a very volatile start to the year. The situation that’s occurring in Ukraine is horrific. What are investors meant to do about these types of events? Stay calm It’s terrible what the people of Ukr...

Rask Media VHT 2 years ago
2 ASX shares every growth investor needs to know about

Every growth investor should want to know about the two ASX shares in this article. A decade ago, some of the ASX’s current blue chip ASX growth shares were much smaller and have gone through a long growth journey to get to where they are...

Motley Fool VHT 2 years ago
2 quality ASX shares I’d buy in February

I really like the look of some high-quality ASX shares that have the potential to create solid long-term returns. There is a lot more volatility this year as investor fears appear to be rising when it comes to interest and inflation. These...

Rask Media VHT 2 years ago
SocPo’s Powerplays: Who’s making a gritty comeback?

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Everyone loves a comeback. Just...

Stockhead VHT 2 years ago
Broker names 3 speculative ASX shares to buy

If you’re an investor with a high tolerance for risk, then you may want to look at the ASX shares listed below. This week the team at Bell Potter put speculative buy ratings on them. Here’s what you need to know: Bubs Australia Ltd (ASX:...

Motley Fool VHT 2 years ago
Never looked better: Volpara Q3 cash receipts up, ARR beats record, powerful on key metrics

Medtech Volpara has delivered another strong quarter of growth as it continues to advance its position in the growing personalised medicine sector. Healthcare technology company Volpara (ASX:VHT) has reported quarterly cash receipts of NZ$...

Stockhead VHT 2 years ago
2 top ASX tech shares for February 2022

Key points There are some high-quality ASX tech shares that have been sold-off, which could be opportunities Doctor Care Anywhere, a telehealth business, is seeing a strong increase in organic revenue and growing its number of patients Vo...

Motley Fool VHT 2 years ago
SocPo’s Powerplays: A few healthcare gems among the carnage

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. During his Australian Open quar...

Stockhead VHT 2 years ago
3 exciting small cap ASX shares to watch

Are you looking to add a small cap share or two to your portfolio in the near future? If you are, then you might want to consider one of the ASX shares listed below. Here’s what you need to know about these exciting small cap shares: Alcid...

Motley Fool VHT 2 years ago
ScoPo’s Powerplays: Healthcare’s game is off, but a comeback is possible

Healthcare and life sciences expert Scott Power,who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. The Australian Open has kicked o...

Stockhead VHT 2 years ago
Top 10 at 10: The ASX stocks playing it safe this morning

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead VHT 2 years ago
VHT – Morgans rates the stock as Add

ShareCafeVHT – Morgans rates the stock as Add Morgans believes there is value (unrecognised by the market) in Volpara Health Technologies’ data set (51m images) that could be worth up to $100m. The broker adopts a changed valuation method a...

ShareCafe VHT 2 years ago
ASX growth shares are on sale, time to load up?

A wide array of different ASX growth shares have been sold off in recent weeks and months. It looks to me like they’re on sale. I think that the weakness of many different share prices looks like a good time to think about buying. It’s true...

Rask Media VHT 2 years ago
2 exciting small cap ASX shares named as buys

If you’re wanting to invest in the small side of the Australian share market, then the small caps listed below could be worth a closer look. Both of these shares have been named as buys and tipped for big things in the future. Here’s why t...

Motley Fool VHT 2 years ago
ScoPo’s Powerplays: For healthcare, a case of nerves ahead of reporting season

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week There’s so...

Stockhead VHT 2 years ago
Are these 2 ASX tech shares good buys in January?

ASX tech shares could be the right place to find opportunities in January 2022. There has been a lot of volatility over the last couple of months, with some businesses dropping (close) to multi-month lows. High-quality businesses that are...

Motley Fool VHT 2 years ago
2 great ASX growth shares I’d buy in 2022

2022 looks like a really good year to look at promising ASX growth shares. Plenty of attractive businesses have seen their share prices drop recently like Webjet Limited (ASX: WEB), Adore Beauty Group Ltd (ASX: ABY) and Temple & Webster...

Rask Media VHT 2 years ago
Here’s what CEOs are hoping to change with their New Year’s resolutions for 2022

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

Stockhead VHT 2 years ago
Waiting for 2022? Here’s a bunch of books CEOs are reading during the holiday break

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

Stockhead VHT 2 years ago
3 exciting small cap ASX shares rated as buys

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been given buy ratings and tipped for big things in the future. Here’s what y...

Motley Fool VHT 2 years ago
CEOs look ahead to three things they’re hoping for in 2022

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

Stockhead VHT 2 years ago
CEOs look back and share their company highlights from 2021

It’s been another year of lockdown and supply challenges for all companies dealing with the COVID-19 variants as they pop up. But with challenges, comes opportunities to learn and grow. So as the end of the year approaches, we took the chan...

Stockhead VHT 2 years ago
Experts rate these 2 ASX healthcare shares as buys in 2022

Some ASX healthcare shares have been rated as buys for 2022 by experts. Healthcare companies have the potential of producing both growth and defensive earnings. People don’t choose when they get sick, and health is very important to most p...

Motley Fool VHT 2 years ago
The bear case for Appen (ASX:APX)

Howdy Folks! We’re trying something new at Rask Media.  It’s called Rask bulls vs bears club.   Two writers will provide the bull and bear case for a popular company our readers are interested in On Friday you would have seen the Appen bull...

Rask Media VHT 2 years ago
2 fast growth ASX shares that could be buys in December 2021

ASX growth shares increasing in size quickly could be contenders for an investor’s portfolio. There is growing volatility in the ASX share market. This may open up some better value opportunities for people to find. Share prices regularly...

Motley Fool VHT 2 years ago
I would buy these ASX growth shares in December 2021

ASX growth shares could be the perfect place to find some long-term opportunities in December 2021. Businesses that are seeing really quick growth of revenue have the potential to become much bigger in the coming years. I think that recent...

Rask Media VHT 2 years ago
FNArena Corporate Results Monitor – 29-11-2021

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((FPH)) - Fisher & Paykel Healthcare ((SHV)) - Select Harvests ((TNE)) - TechnologyOne ((VHT)) - Volpara Health Technologies Check it out at https://www.fnarena.com/i...

FNArena VHT 2 years ago
ScoPo’s Powerplays: Christmas rally runs out of puff, but market awaits crucial release from Neuren

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week At the time...

Stockhead VHT 2 years ago
Check Up: Sustainable Nutrition riding high and Singular Health branches out from… health

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Stockhead VHT 2 years ago
Volpara (ASX:VHT) share price rises after strong HY22

The Volpara Health Technologies Ltd (ASX: VHT) share price is rising after the healthcare business released its HY22 result. Volpara is a medical technology business which specialises in breast screening for cancer. The business also has a...

Rask Media VHT 2 years ago
Best-ever result: Volpara Health (ASX:VHT) share price jumps on half-year update

The Volpara Health Technologies Ltd (ASX: VHT) share price is in the green in early trade today, up 2.9% to $1.06. Investors are pushing up Volpara Health shares after the medical technology software as a service (SaaS) player released its...

Motley Fool VHT 2 years ago
ScoPo’s Powerplays: Investors look to Healthcare for ESG exposure, and Volpara is the poster child

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week The Healthc...

Stockhead VHT 2 years ago
Have money to invest? Here are 2 ASX shares that could be potential buys

If investors have got money to invest, then there could be some compelling ASX share ideas to consider for the long-term. Businesses that are displaying growth, or have plans for growth, could be worth considering. Here are two ASX shares...

Motley Fool VHT 2 years ago
3 exciting small cap ASX shares to watch

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been tipped for big things in the future. Here’s why these small cap ASX shar...

Motley Fool VHT 2 years ago
‘Delivering in all aspects’: Volpara strengthens and expands as personalised medicines sector leader

Medtech Volpara is consolidating its leading position in the growing personalised medicine sector, gaining attention of both the health sector and investors. Momentum in healthcare technology company Volpara (ASX:VHT)  is continuing to gro...

Stockhead VHT 2 years ago